title: Infectious scleritis after use of immunomodulators.
authors.affiliation: Department of Ophthalmology, Chang Gung Memorial Hospital, No. 199, Tung Hwa North Road, Taipei 105, Taiwan, Republic of China.
authors.forename: Yih-Shiou
authors.initials: YS
authors.lastname: Hwang
authors.forename: Yeong-Fong
authors.initials: YF
authors.lastname: Chen
authors.forename: Chi-Chun
authors.initials: CC
authors.lastname: Lai
authors.forename: Henry Shen-Lih
authors.initials: HS
authors.lastname: Chen
authors.forename: Ching-Hsi
authors.initials: CH
authors.lastname: Hsiao
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000628:therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D015251:Epirubicin / Q000627:therapeutic use; D015818:Eye Infections, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D008408:Mastectomy; D008875:Middle Aged; D012590:Sclera / Q000382:microbiology; D015423:Scleritis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D016868:Serratia Infections / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D012706:Serratia marcescens / Q000302:isolation & purification*
chemical_list: D000276:Adjuvants, Immunologic; D000900:Anti-Bacterial Agents; D005839:Gentamicins; D015251:Epirubicin; D003520:Cyclophosphamide